Total Funding
78
78
Total FundingPost-IPO Debt raised
Growth Score
-2 pts
Heat Score
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29707
Oncocross is a biotechnology company that uses artificial intelligence to develop new drugs for cancers.
- Jihoon Kang: Chief Executive Officer
- Jihoon Kang: Vice President, Chief Medical Officer
About the Company
Oncocross is an AI-driven biotechnology company that specializes in transcriptome-based drug discovery, precision oncology, and AI-powered drug repurposing technologies. The company develops treatments for cancers, rare diseases, and intractable diseases using proprietary AI platforms and multi-omics data analysis. The company combines AI analytics
with in-house in vitro and in vivo validation experiments to accelerate drug development and improve clinical success rates.
